Original Article

You have full text access to this OnlineOpen article

Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension

  1. Michael J. Krowka M.D. M.D.1,*,
  2. Robert P. Frantz2,
  3. Michael D. McGoon2,
  4. Cathy Severson2,
  5. David J. Plevak3,
  6. Russell H. Wiesner4

Article first published online: 30 DEC 2003

DOI: 10.1002/hep.510300307

Issue

Hepatology

Hepatology

Volume 30, Issue 3, pages 641–648, September 1999

Additional Information

How to Cite

Krowka, M. J., Frantz, R. P., McGoon, M. D., Severson, C., Plevak, D. J. and Wiesner, R. H. (1999), Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension. Hepatology, 30: 641–648. doi: 10.1002/hep.510300307

Author Information

  1. 1

    Division of Pulmonary and Critical Care Medicine, Mayo Clinic and Mayo Foundation, Rochester, MN

  2. 2

    Division of Cardiovascular Diseases, Mayo Clinic and Mayo Foundation, Rochester, MN

  3. 3

    Department of Anesthesiology, Mayo Clinic and Mayo Foundation, Rochester, MN

  4. 4

    Division of Gastronterology and Hepatology, Mayo Clinic and Mayo Foundation, Rochester, MN

*Mayo Clinic, E18A 200 First Street, SW, Rochester, MN 55905. fax: (507) 266-4372

Publication History

  1. Issue published online: 30 DEC 2003
  2. Article first published online: 30 DEC 2003
  3. Manuscript Accepted: 8 JUN 1999
  4. Manuscript Received: 27 JAN 1999

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (125K)

References

  • 1
    Rich S, Dantzker DR, Ayers SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP. Primary pulmonary hypertension: a national prospective study. Ann Intern Med 1987; 107:216–223. MEDLINE
  • 2
    Herve P, Lebrec D, Brenot F, Simonneau G, Humbert M, Sitbon O, Duroux P. Pulmonary vascular disorders in portal hypertension. Eur Respir J 1998; 11:1153–1166. MEDLINE
  • 3
    Kuo PC, Plotkin JS, Rubin LJ. Distinctive clinical features of portopulmonary hypertension. Chest 1997; 112:980–986. MEDLINE
  • 4
    Edwards BS, Weir EK, Edwards WD, Ludwig J, Dykaski RK, Edwards JE. Co-existent pulmonary and portal hypertension: morphologic and clinical features. J Am Coll Cardiol 1987; 10:1233–1238. MEDLINE
  • 5
    Krowka MJ. Hepatopulmonary hypertension and portopulmonary hypertension: distinctions and dilemmas. Hepatology 1997; 25:1282–1284. MEDLINE
    Direct Link:
  • 6
    Edwards WD. Pulmonary hypertension and related diseases. In: StehbeusWE, LieJT, eds. Vascular Pathology. London: Chapman and Hall Medical, 1995; 585–621.
  • 7
    Martinez EJ, Wright RK, Schiff ER, Tzakis AG, Krowka MJ. Portopulmonary hypertension and liver transplantation: why we fail. Hepatology 24: 585–621.
  • 8
    Robalino BD, Moodie DS. Association between primary pulmonary hypertension and portal hypertension: analysis of its pathophysiology, clinical laboratory, and hemodynamic manifestations. J Am Coll Cardiol 1991; 17:492–499. MEDLINE
  • 9
    Mandell MS, Groves BM. Pulmonary hypertension in chronic liver disease. Clin Chest Med 1996; 17:17–33. MEDLINE
  • 10
    Barst RJ, Rubin LJ, Long WA, McGoon MD, Rich S, Badesch DB, Groves MB, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 1996; 334:296–301. MEDLINE
  • 11
    McLaughlin VV, Genthner DE, Panella MM, Rich S. Reduction in pulmonary vascular resistance with long term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. N Engl J Med 1998; 338:272–277.
  • 12
    Kim R, Krowka MJ, Plevak DJ, Frantz R, Wiesner RH. Moderate to severe portopulmonary hypertension: important correlates with Doppler echocardiography in liver transplant patients. Hepatology 28: 272–277.
  • 13
    Rubin LJ, Groves BM, Reeves JT, Frosolano M, Handel F, Cato AE. Prostacyclin-induced acute pulmonary vasodilatation in primary pulmonary hypertension. Circulation 1982; 2:334–338.
  • 14
    Groves BM, Rubin LJ, Frosolano MF, Cato AE, Reeves JT. A comparison of acute hemodynamic effects of prostacyclin and hydralazine in primary pulmonary hypertension. Am Heart J 1985; 110:1200–1204. MEDLINE
  • 15
    Jones DK, Higenbottam TW, Wallwork J. Treatment of primary pulmonary hypertension with intravenous epoprostenol (prostacyclin). Br Heart J 1987; 57:270–278. MEDLINE
  • 16
    Weir EK, Rubin LJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Elliot CG, et al. The acute administration of vasodilators in primary pulmonary hypertension. Am Rev Respir Dis 1989; 140:1623–1630. MEDLINE
  • 17
    Palevsky HI, Long W, Crow J, Fishman AP. Prostacyclin and acetlycholine as screening agents for acute pulmonary vasodilator responsiveness in primary pulmonary hypertension. Circulation 1990; 82:2018–2026. MEDLINE
  • 18
    Nootens M, Schrader B, Kaufmann E, Vestal R, Long W, Rich S. Comparative acute effects of adenosine and prostacyclin in primary pulmonary hypertension. Chest 1995; 107:54–57. MEDLINE
  • 19
    Raffy O, Azarian R, Brenot F, Parent F, Sitbon O, Petitpretz P, Herve P, et al. Clinical significance of pulmonary vasodilator response during short-term infusion of prostacyclin in primary pulmonary hypertension. Circulation 1996; 93:484–488. MEDLINE
  • 20
    Palevsky HI, Fishman AP. The management of primary pulmonary hypertension. JAMA 1991; 8:1014–1020.
  • 21
    Botney MD. Role of hemodynamics in pulmonary vascular remodeling. Am J Respir Crit Care Med 1999; 159:361–364. MEDLINE
  • 22
    Kuo PC, Plotkin JS, Howell CD, Bartlett ST, Rubin LJ. Continuous infusion of epoprostenol for the treatment of portopulmonary hypertension. Transplantation 1997; 63:604–606. MEDLINE
  • 23
    Plotkin JS, Kuo PC, Rubin LJ, Gaine S, Howell CD, Laurin J, Njoku MJ, et al. Successful use of chronic epoprostenol as a bridge to liver transplantation in severe portopulmonary hypertension. Transplantation 1998; 65:457–459. MEDLINE
  • 24
    Ramsay MAE, Simpson BR, Nguyen AT, Ramsay K, East C, Klintmalm GB. Severe hypertension in liver transplant candidates. Liver Transplant Surg 1997; 3:494–500.
    Direct Link:
Get PDF (125K)